Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials)

American Journal of Cardiology

Volumn 85, Issue 12, 2000, Pages 1409-1413

  Llevadot, Joan ^a   Giugliano, Robert P ^a   McCabe, Carolyn H ^a   Cannon, Christopher P ^a   Antman, Elliott M ^a   Murphy, Sabina ^b   Gibson, C Michael ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; ANISTREPLASE; GLYCERYL TRINITRATE; TENECTEPLASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CLINICAL TRIALS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 0034659996     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00786-4     Document Type: Article

References (30)

1. Schweiger M.J., McMahon R.P., Terrin M.L., Ruocco N.A., Porway M.N., Wiseman A.H., Knatterud G.L., Braunwald E. Comparison of patients with <60% to ≥60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. Am J Cardiol. 74:1994;105-110.
2. Goldberg R.K., Kleiman N.S., Minor S.T., Abukhalil J., Raizner A.R. Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA. Am Heart J. 119:1990;178-184.
3. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
4. Gibson C.M., Murphy S.A., Rizzo M.J., Ryan K.A., Marble S.J., McCabe C.H., Cannon C.P., Van de Werf F., Braunwald E. The relationship between the TIMI Frame Count and clinical outcomes after thrombolytic administration. Circulation. 99:1999;1945-1950.
5. Cannon C.P., McCabe C.H., Diver D.J., Herson S., Greene R.M., Shah P.K., Sequeira R.F., Leya F., Kirshenbaum J.M., Magorien R.D., Palmeri S.T., Davis V., Gibson C.M., Poole W.K., Braunwald E. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction ;Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial . J Am Coll Cardiol. 24:1994;1602-1610.
6. Cannon C.P., McCabe C.H., Gibson C.M., Ghali M., Sequeira R.F., McKendall G.R., Breed J., Modi N.B., Fox N.L., Tracy R.P., Love T.W., Braunwald E. TNK-tissue plasminogen activator in acute myocardial infarction results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial . Circulation. 95:1997;351-356.
7. Cannon C.P., Gibson C.M., McCabe C.H., Adgey A.A.J., Schweiger M.J., Sequeira R.F., Grollier G., Giugliano R.P., Frey M., Mueller H.S., Steingart R.M., Weaver W.D., Van de Werf F., Braunwald E. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction results of the TIMI 10B Trial . Circulation. 98:1998;2805-2814.
8. Antman E.M., Giugliano R.P., Gibson C.M., McCabe C.H., Coussement P., Kleiman N.S., Vahanian A., Adgey A.A.J., Menown I., Rupprecht H.J., et al. Abciximab facilitates the rate and the extent of thrombolysis Results of TIMI 14 trial . Circulation. 99:1999;2720-2732.
9. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med. 31:1985;932-936.
10. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T. Jr, Alexander B., Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., Braunwald E. The TIMI frame count A quantitative method of assessing coronary artery flow . Circulation. 93:1996;879-888.
11. Gibson C.M., Sandor T., Stone P.H., Pasternak R.C., Rosner B., Sacks F.M. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol. 69:1992;1286-1290.
12. Hackett D., Davies G., Maseri A. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J. 9:1988;1317-1323.
13. Kereiakes D.J., Topol E.J., George B.S., Stack R.S., Abbottsmith C.W., Ellis S., Candela R.J., Harrelson L., Martin L.H., Califf R.M. Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. J Am Coll Cardiol. 17:1991;304-312.
14. Reiner J.S., Lundergan C.F., Fung A., Coyne K., Cho S., Israel N., Kazmierski J., Pilcher G., Smith J., Rohrbeck S., Thompson M., Van de Werf F., Ross A.M. Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. Circulation. 94:1996;2441-2446.
15. McKena W.J., Chew C.Y., Oakley C.M. Myocardial infarction with normal coronary angiogram possible mechanism of smoking risk in coronary artery disease . Br Heart J. 43:1980;493-498.
16. Slone D., Shapiro S., Rosenberg L., Kaufman D.W., Hartz S.C., Rossi A.C., Stolley P.D., Miettinen O.S. Relation of cigarette smoking to myocardial infarction in young women. N Engl J Med. 298:1978;1273-1276.
17. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 321:1989;129-135.
18. Garcia-Dorado D., Theroux P., Tornos P., Sambola A., Oliveras J., Santos M., Soler Soler J. Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes. Circulation. 92:1995;1743-1748.
19. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 . Lancet. 2:1988;349-360.
20. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J. 296:1988;320-331.
21. Gould K.L., Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 34:1971;48-55.
22. Wijns W., Serruys P.W., Reiber J.H., Van den Brand M., Simoons M.L., Kooijman C.J., Balakumaran K., Hugenholtz P.G. Quantitative angiography of the left anterior descending coronary artery correlations with pressure gradient and results of exercise thallium scintigraphy . Circulation. 71:1985;273-279.
23. Ueda Y., Asakura M., Hirayama A., Komanura K., Hori M., Kodama K. Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction serial angioscopic observations . J Am Coll Cardiol. 27:1996;606-610.
24. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., Hjemdahl-Monsen C.E., Leavy J., Weiss M., Borrico S., Gorlin R., Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 12:1988;56-62.
25. Little W.C., Constantinescu M., Applegate R.J., Kutcher M.A., Burrows M.T., Kahl F.R., Santamore W.P. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 78:1988;1157-1166.
26. Nobuyoshi M., Tanaka M., Nosaka H., Kimura T., Yokoi H., Hamasaki N., Kim K., Shindo T., Kimura K. Progression of coronary atherosclerosis is coronary spasm related to progression? J Am Coll Cardiol. 18:1991;904-910.
27. Giroud D., Li J.M., Urban P., Meier B., Rutishauser W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol. 69:1992;729-732.
28. Alderman E., Corley S.D., Fisher L.D., Chaitman B.R., Faxon D.P., Foster E.D., Killip T., Sosa J.A., Bourassa M.G. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 22:1993;1141-1154.
29. Ledru F., Theroux P., Lesperance J., Laurier J., Ducimetiere P., Guermonprez J.L., Diebold B., Blanchard D. Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction a quantitative angiographic study . J Am Coll Cardiol. 33:1999;1353-1361.
30. Cohen M., Sherman W., Rentrop K.P., Gorlin R. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol. 13:1989;297-303.